Abrazo Arrowhead Campus is transforming neurological care for critically ill patients with the adoption of the Ceribell System, an electroencephalography (EEG) device powered by artificial intelligence that enables doctors to quickly find and diagnose non-convulsive seizures.
“Non-convulsive seizures are a big challenge in acute care,” says Dr. Laxmi Dhakal, Medical Director of Neurology, Abrazo Arrowhead Campus.
“This type of seizure often occurs without obvious signs or symptoms, making them difficult to detect and often delaying treatment. Like convulsive seizures, without prompt management and anti-seizure medication, the situation can rapidly become more difficult to manage, and potentially lead to cognitive morbidity and mortality,” says Dr. Dhakal.
Non-convulsive seizures are prevalent in patients with conditions such as brain injuries, cardiac arrest and/or stroke, and like strokes, ‘time is brain’ for seizures — prompt diagnosis and intervention are critical as treatment efficacy declines with every hour of delay.
This brings cutting-edge brain diagnostic technology into our diagnostic toolkit and allows us to use AI to save valuable time and change how we assess and treat our critically ill neurology patients,” explained Dr. Sushant Kale, Neurointerventionist and Market Medical Director for Stroke and Interventional Neurology, Abrazo Health.
How does it work? “When or if a patient is clinically suspected of having a non-convulsive seizure, doctors apply a Ceribell headband to the patient’s head at bedside and then the AI can detect suspected seizures right away with very high clinical accuracy,” says Dr. Kale.
“At Abrazo Arrowhead, we are committed to advancing healthcare through this type of innovative technology as we continue to deliver the highest quality care to our patients in the West Valley,” says Stephen Gardner, CEO, Abrazo Arrowhead Campus.
The technology is not meant to replace conventional EEG monitoring; it’s a complementary solution that enables expanded EEG coverage throughout the hospital, so clinicians can quickly and more accurately diagnose and manage seizures in the acute care setting, which may reduce the need to transfer patients to other facilities and help improve patient outcomes.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter |The Mainstream formerly known as CIO News Whatsapp Channel | The Mainstream formerly known as CIO News Instagram
About us:
The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.
